Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Edoxaban for venous thromboembolism treatment—the new kid on the block for Latin America. A practical guide
E Ramacciotti, VCR Aguiar, VC Júnior… - Clinical and Applied …, 2018 - journals.sagepub.com
Edoxaban, a direct factor Xa inhibitor (FXa), is the fourth direct oral anticoagulant (DOAC)
approved for clinical use in the treatment of venous thromboembolism (VTE) in Latin …
approved for clinical use in the treatment of venous thromboembolism (VTE) in Latin …
Biosimilar versus branded enoxaparin to prevent postoperative venous thromboembolism after surgery for digestive tract cancer: Randomized trial
Cancer and/or major surgery are two factors that predispose to post-operative thrombosis.
The annual incidence of venous thromboembolic disease (VTED) in cancer patients was …
The annual incidence of venous thromboembolic disease (VTED) in cancer patients was …
Comparative studies on the anticoagulant profile of branded enoxaparin and a new biosimilar version
D Qneibi, E Ramacciotti, AS Macedo… - Clinical and Applied …, 2020 - journals.sagepub.com
Low molecular weight heparins (LMWH) represent depolymerized heparin prepared by
various methods that exhibit differential, biochemical and pharmacological profiles …
various methods that exhibit differential, biochemical and pharmacological profiles …
Safety and effectiveness of biosimilar enoxaparin (Inhixa) for the prevention of thromboembolism in medical and surgical inpatients
C Fantoni, L Bertù, EM Faioni, C Froiio… - Internal and emergency …, 2021 - Springer
In 2016, biosimilar enoxaparin (Inhixa®, Techdow) was introduced in European markets
with the same indications as branded enoxaparin (Clexane®, Sanofi). Its use is constantly …
with the same indications as branded enoxaparin (Clexane®, Sanofi). Its use is constantly …
[PDF][PDF] HEPARINAS DE BAJO PESO MOLECULAR EN LA ENFERMEDAD TROMBOEMBÓLICA VENOSA
EMSN García, NC Revuelta, ÁR Calavia, CV Puerta - capitulodeflebologia.org
Las heparinas de bajo peso molecular (HBPM) se emplean en la profilaxis de la
enfermedad tromboembólica venosa (ETEV) y en el tratamiento de la trombosis venosa …
enfermedad tromboembólica venosa (ETEV) y en el tratamiento de la trombosis venosa …